A pre-sale valuation review is the single most useful piece of work an owner can commission in the eighteen months leading up to a planned exit. It is a focused engagement, usually completed in two to four weeks, that produces three deliverables: a realistic indicative valuation of the business as it stands today, a gap analysis between that figure and the owner's target number, and a prioritised list of specific value-uplift actions to close the gap over the available time. The work is not a sale-process document, not a marketing brochure, and not an exercise in optimistic forecasting. It is an internal, honest, working document designed to inform the decisions the owner will make over the run-up to going to market.
The review pays back in two distinct ways. The first and most measurable is the additional price achieved at sale: the value-uplift plan, executed over twelve to twenty-four months, typically delivers a multiple expansion and structural improvement worth ten to forty percent of enterprise value, against a cost of the review itself measured in low five figures. The second is the avoided cost of going to market with the wrong expectations: owners who skip this step and discover their assumptions are wrong only when the first offers come in lose months of management attention to a process they then have to abort, often damaging the business in the meantime and arriving back at the table eighteen months later with a worse story than they started with.
This article sets out what the review actually covers, what owners typically discover, how the gap analysis and uplift plan are structured, and how the work translates into a higher transaction outcome when the time comes to sell.
What the review covers
The first component is a current-state valuation built from the same methodology a serious buyer would use. The valuer normalises EBITDA against the buyer-side conventions described in the project's pillar guides. Owner remuneration to market rate, genuinely one-off costs added back with supporting evidence, run-rate adjustments applied conservatively, maintainable capex normalised against a bottom-up replacement schedule, working capital benchmarked against a twelve-to-twenty-four-month average. The output is an indicative range, not a single number, with the bottom of the range representing what a defensive financial buyer would likely pay and the top representing what a competitive process with a credible strategic acquirer could achieve.
The second component is a structured risk diagnostic against the factors that buyers consistently price. Customer concentration is mapped against revenue and gross margin, with top-account share and trailing-twelve-month trends. Owner-dependency is assessed through a decision-mapping exercise. What decisions in the business genuinely require the owner, how often, and what would happen in their absence. Management depth is evaluated against the second-tier criteria buyers actually test for. Contract quality is reviewed for written-versus-verbal status, notice periods, change-of-control language and renewal mechanics. Recurring revenue is classified rigorously against contracted, scheduled and switching-cost-protected criteria. Each risk factor is scored against benchmark and the implied price impact is quantified.
The third component is the gap analysis. The owner's target number. Either the figure they need to retire on, the figure they have informally been led to expect, or simply the figure they consider a successful outcome. Is compared against the current-state range. The gap is decomposed: how much of it is closable through realistic operational improvement, how much through structural changes (recurring revenue, contracts, management depth), how much through better preparation for the sale process itself, and how much is simply the owner's expectations being out of step with what the market will actually pay.
The fourth component is the prioritised uplift plan. Each potential intervention is sized for its expected impact on enterprise value, the timeline required, the cost (financial and managerial), and the risk of execution failure. The plan presents the interventions in order of return-on-effort, with a clear recommendation on which to pursue in the available window. Owners are not given a long wishlist of theoretical improvements; they are given the three to six things that will actually move the price, sized and sequenced.
What owners typically discover
The most common finding is that the target number is achievable, but not on today's numbers and not on today's structure. The owner's instinct about what the business is worth is often broadly correct as an end-state, but the gap between where the business is now and where it needs to be to support that valuation is wider than the owner had assumed. Recognising the gap eighteen months early, with a plan to close it, is a very different situation from discovering the gap during a live sale process when there is no time to act.
The second common finding is that the cheapest uplift comes from fixing things the owner already knew were weak. Customer concentration, owner-dependency, soft contracts, an under-developed second tier. The owner has typically been aware of these issues for years and has rationalised them as 'we'll get to that' or 'it's not that big a deal'. The review quantifies what each one is actually costing in the eventual sale price, and the numbers are usually large enough to make the previously deferred work look urgent.
The third common finding is the inverse of the first: owners whose target number is materially above what the business can realistically support. This is not pleasant news, but it is far better delivered eighteen months before a planned sale than discovered in the first round of offers. With the gap honestly quantified, the owner has three credible options. Extend the timeline to allow more value-building work, recalibrate expectations and proceed at an honest valuation, or restructure the exit (partial sale, EOT, MBO, deferred exit) to bridge the gap through structure rather than headline price. All three are better than going to market on assumptions the market will not validate.
The fourth common finding is that the seller-side EBITDA story they have been telling themselves does not survive scrutiny. Add-backs they considered obvious are rejected. Run-rate adjustments they had baked in are discounted. Maintainable capex turns out to be higher than the historic average suggested. The result is a normalised EBITDA noticeably lower than the figure they had in their head, and a current-state valuation correspondingly lower than expected. The review's value here is to expose the gap early enough that the underlying performance can actually be improved, rather than after the buyer's quality-of-earnings team has done the same work and chipped the price.
How the uplift plan translates into a higher transaction price
The plan typically combines four categories of intervention, sized against the available time. The first is operational performance: lifting EBITDA itself through pricing discipline, cost normalisation, productivity work and concentration-reduction. Even modest increases in adjusted EBITDA convert directly into enterprise value at the prevailing multiple, and the cumulative effect over twelve to twenty-four months is often substantial.
The second category is multiple-expanding structural change: building the recurring-revenue base, converting verbal arrangements into written contracts, recruiting or promoting a credible second tier of management, documenting processes, formalising IP. Each of these moves the multiple the buyer is willing to apply, typically by a quarter to a full turn of EBITDA depending on the starting point.
The third category is risk reduction that protects the price from chips in diligence: cleaning up the cap table, resolving any open tax or legal issues, formalising employment terms, sorting out shareholder agreements, addressing concentration risks the buyer would otherwise discount. The price effect here is not a headline uplift but a reduction in the cumulative diligence chip. A defensive intervention that preserves the value the other interventions create.
The fourth category is sale-process readiness: building the data room early, preparing the quality-of-earnings analysis in seller-side form, drafting the management presentation, lining up the advisory team. This work does not change the underlying value of the business but it does ensure that the value is realised cleanly when the process runs, with fewer surprises, less re-trading, and a faster path to completion.
The combined effect, over a properly executed twelve-to-twenty-four-month uplift plan, is regularly an enterprise-value uplift in the range of fifteen to forty percent against the starting baseline, and the structural improvements (more cash at completion, shorter earn-out, cleaner warranties) often add another ten percent in present-value terms on top of that.
Why owners who skip the review consistently regret it
The most common pattern in unsuccessful UK SME sales is an owner who goes to market without ever having had an honest external view of what the business is actually worth and what would have to be true for the price to be higher. The first offers come in materially below expectations. The owner spends six months trying to negotiate the price up without changing the underlying analysis the buyers have done, which never works. The process either completes at a disappointing price or aborts entirely. The owner returns to the business eighteen months older, with a now-stale data set, a tired management team, and the additional disadvantage of being known in the market as having tried and failed. A pre-sale valuation review eighteen months earlier would have avoided all of this, almost regardless of what it had found.
Questions & Answers
Quick reference answers to the questions UK SME owners most often ask on this topic.
When in the planning cycle should I commission a pre-sale valuation review?
Eighteen to twenty-four months before the intended sale date is the working sweet spot. Earlier than two years and the underlying business will have changed materially by the time you go to market, which limits the relevance of the specific recommendations. Later than twelve months and the time available to execute the uplift plan is too short for the most valuable interventions. Building management depth, converting revenue onto a recurring footing, demonstrating contract renewal histories, to register fully in the buyer's eyes. The lead time is the single biggest determinant of how much value the review unlocks.
How much does a pre-sale valuation review typically cost?
For a UK SME at the £500k to £5m EBITDA range, a properly scoped review is generally a low-five-figure exercise. Usually in the £5,000 to £15,000 range depending on the complexity of the business, the depth of normalisation work required, and whether sector-specific commercial analysis is included. Against a typical uplift in enterprise value of ten to forty percent on a successful execution. Measured in hundreds of thousands of pounds for most SMEs. The payback ratio is generally between ten and a hundred times the cost. The review is one of the highest-ROI pieces of professional work available to an SME owner.
Will the review give me a valuation I can rely on for HMRC or other formal purposes?
No, and it should not be treated as one. A pre-sale valuation review is an internal working document built around what a market buyer would likely pay; it is not a formal valuation report intended to defend itself in front of HMRC, a court, an EOT trustee or a shareholder-dispute arbitrator. Where a formal valuation is required for those purposes, a separate engagement is needed. Usually with a different methodology and a signed report. Many owners commission both at different points in their planning, since the formal report and the strategic review answer different questions.
What if I cannot execute the recommended uplift plan in the time I have?
That is itself a valuable finding. The honest options at that point are to extend the sale timeline to allow the work to be done properly, to proceed with a more limited uplift plan and accept a lower price, or to restructure the exit so that more of the value transfers through deferred or contingent mechanisms (earn-out, vendor loan notes, partial sale, EOT). All three are credible responses, and the review is what allows you to choose between them with full information rather than discovering the constraint mid-process when the room to manoeuvre has closed.
Will the review process disrupt the business?
It should not. A well-scoped review draws on financial information that already exists, brief management interviews (usually a couple of hours per member of the senior team), and an external review of customer, contract and operational data the business can compile in advance. Most engagements are completed in two to four weeks of elapsed time with limited day-to-day disruption. The follow-on uplift plan does require management attention to execute, but that work is the value of the engagement. The diagnostic itself is light-touch.
What is the difference between a pre-sale valuation review and an information memorandum?
An information memorandum is a marketing document produced at the start of a live sale process to present the business to prospective buyers in the most attractive credible form. A pre-sale valuation review is an internal diagnostic produced twelve to twenty-four months earlier, designed to identify what needs to change before the IM can credibly support the price the owner wants. The two are sequential rather than alternative, and skipping the review usually results in an IM that overstates the value and a process that consequently disappoints.
Written by
Tony Vaughan
Senior SME valuation adviser, 2,500+ business value appraisals.
